Clopidogrel bisulfate and Colon cancer - a phase IV clinical study of FDA data
Colon cancer is found among people who take Clopidogrel bisulfate, especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Clopidogrel bisulfate and have Colon cancer. It is created by eHealthMe based on reports of 15,280 people who have side effects when taking Clopidogrel bisulfate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
15,280 people reported to have side effects when taking Clopidogrel bisulfate.
Among them, 29 people (0.19%) have Colon cancer.
What is Clopidogrel bisulfate?
Clopidogrel bisulfate has active ingredients of clopidogrel bisulfate. It is often used in blood clots. eHealthMe is studying from 15,490 Clopidogrel bisulfate users for its effectiveness, alternative drugs and more.
What is Colon cancer?
Colon cancer is found to be associated with 1,813 drugs and 1,117 conditions by eHealthMe.
Number of Clopidogrel bisulfate and Colon cancer reports submitted per year:
Time on Clopidogrel bisulfate when people have Colon cancer *:
- < 1 month: 16.67 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 50.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Colon cancer when taking Clopidogrel bisulfate *:
- female: 58.62 %
- male: 41.38 %
Age of people who have Colon cancer when taking Clopidogrel bisulfate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 17.86 %
- 60+: 82.14 %
Common drugs people take besides Clopidogrel bisulfate *:
- Aspirin: 6 people, 20.69%
- Apixaban: 4 people, 13.79%
- Plavix: 4 people, 13.79%
- Heparin: 4 people, 13.79%
- Pitavastatin Calcium: 3 people, 10.34%
- Simvastatin: 3 people, 10.34%
- Carvedilol: 3 people, 10.34%
- Omeprazole: 3 people, 10.34%
- Diovan: 3 people, 10.34%
- Calciparine: 3 people, 10.34%
Common side effects people have besides Colon cancer *:
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 8 people, 27.59%
- Headache (pain in head): 3 people, 10.34%
- Stress And Anxiety: 3 people, 10.34%
- Blood Creatinine Increased: 3 people, 10.34%
- Intestinal Haemorrhage (bleeding from intestine): 3 people, 10.34%
- Rectosigmoid Cancer (cancer that originates in the rectum and sigmoid colon): 3 people, 10.34%
- Anaemia (lack of blood): 3 people, 10.34%
- Hyperglycemia (high blood sugar): 3 people, 10.34%
- Nausea And Vomiting: 3 people, 10.34%
- Iron Deficiency Anaemia: 2 people, 6.90%
Common conditions people have *:
- Cardiac Failure: 7 people, 24.14%
- Dyslipidaemia (abnormal amount of lipids): 6 people, 20.69%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 5 people, 17.24%
- Cardiac Failure Chronic: 5 people, 17.24%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 17.24%
- Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 4 people, 13.79%
- Constipation: 4 people, 13.79%
- Hypertriglyceridaemia (excess of triglycerides in the blood): 4 people, 13.79%
- Stable Angina (a constant chest pain): 3 people, 10.34%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 10.34%
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel bisulfate and have Colon cancer?Check whether Colon cancer is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Colon cancer and when was it recovered:
Expand to all the drugs that have ingredients of clopidogrel bisulfate:
Alternative drugs to, pros and cons of Clopidogrel bisulfate:
- Clopidogrel bisulfate (15,490 reports)
Common Clopidogrel bisulfate side effects:
- Breathing difficulty: 947 reports
- Heart attack: 884 reports
- Fatigue (feeling of tiredness): 873 reports
- Dizziness: 749 reports
- Weakness: 735 reports
- Chest pain: 727 reports
- Drug ineffective: 725 reports
Browse all side effects of Clopidogrel bisulfate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Colon cancer treatments and more:
- Colon cancer (112,625 reports)
COVID vaccines that are related to Colon cancer:
- Colon cancer in Moderna COVID Vaccine
- Colon cancer in Pfizer BioNTech Covid Vaccine
- Colon cancer in Johnson and Johnson Covid Vaccine
Common drugs associated with Colon cancer:
- Zantac: 38,438 reports
- Ranitidine: 19,493 reports
- Ranitidine hydrochloride: 7,581 reports
- Methotrexate: 777 reports
- Humira: 698 reports
- Aspirin: 672 reports
- Stivarga: 600 reports
- Prednisone: 567 reports
- Enbrel: 560 reports
- Fluorouracil: 549 reports
All the drugs that are associated with Colon cancer:
- Colon cancer (1,813 drugs)
Common conditions associated with Colon cancer:
- Indigestion: 28,994 reports
- Gastroesophageal reflux disease: 15,006 reports
- Gastric ulcer: 3,331 reports
- Rheumatoid arthritis: 1,485 reports
- High blood pressure: 1,036 reports
All the conditions that are associated with Colon cancer:
- Colon cancer (1,117 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel bisulfate (the active ingredients of Clopidogrel bisulfate) and Clopidogrel bisulfate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clonidine and Transplant Rejection - a second ago
- Clonidine and Graft Haemorrhage - a second ago
- Antivert and Basedow'S Disease - 9 seconds ago
- Extradural Abscess and drugs of ingredients of diphenhydramine hydrochloride - 9 seconds ago
- Cosentyx and Hepatic Encephalopathy - 10 seconds ago
- Dalmane and Neuropathy - Peripheral - 10 seconds ago
- Dalmane and Peripheral Neuropathy - 10 seconds ago
- Cyclophosphamide and Eye Infection Fungal - 18 seconds ago
- Cymbalta and Protein Urine - 19 seconds ago
- Crestor and Gingival Pain - 21 seconds ago